These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

4479 related items for PubMed ID: 3127479

  • 41. Pigment content of cultured human melanocytes does not correlate with tyrosinase message level.
    Naeyaert JM, Eller M, Gordon PR, Park HY, Gilchrest BA.
    Br J Dermatol; 1991 Oct; 125(4):297-303. PubMed ID: 1720016
    [Abstract] [Full Text] [Related]

  • 42. Mammalian tyrosinase: isolation by a simple new procedure and characterization of its steric requirements for cofactor activity.
    Hearing VJ, Ekel TM, Montague PM, Hearing ED, Nicholson JM.
    Arch Biochem Biophys; 1978 Jan 30; 185(2):407-18. PubMed ID: 415664
    [No Abstract] [Full Text] [Related]

  • 43. T311--an anti-tyrosinase monoclonal antibody for the detection of melanocytic lesions in paraffin embedded tissues.
    Jungbluth AA, Iversen K, Coplan K, Kolb D, Stockert E, Chen YT, Old LJ, Busam K.
    Pathol Res Pract; 2000 Jan 30; 196(4):235-42. PubMed ID: 10782467
    [Abstract] [Full Text] [Related]

  • 44. Characterization and distribution in human tissues of a glycoproteic antigen defined by monoclonal antibody 1BE12 raised against the human breast cancer cell line T47D.
    Pancino G, Charpin C, Osinaga E, Betaille B, Le Roy M, Calvo F, Roseto A.
    Cancer Res; 1990 Nov 15; 50(22):7333-42. PubMed ID: 2224861
    [Abstract] [Full Text] [Related]

  • 45. Tyrosinase activity in serum from patients with malignant melanoma.
    Agrup P, Carstam R, Wittbjer A, Rorsman H, Rosengren E.
    Acta Derm Venereol; 1989 Nov 15; 69(2):120-4. PubMed ID: 2564228
    [Abstract] [Full Text] [Related]

  • 46. Effects of actinomycin D and cycloheximide on the increase in tyrosinase activity of hamster amelanotic melanoma cells in vitro.
    Słomiński A, Bomirski A, Scisłowski PW, Zołnierowicz S.
    Biosci Rep; 1984 Dec 15; 4(12):1059-64. PubMed ID: 6442169
    [Abstract] [Full Text] [Related]

  • 47. Tyrosinases of murine melanocytes with mutations at the albino locus.
    Halaban R, Moellmann G, Tamura A, Kwon BS, Kuklinska E, Pomerantz SH, Lerner AB.
    Proc Natl Acad Sci U S A; 1988 Oct 15; 85(19):7241-5. PubMed ID: 3140237
    [Abstract] [Full Text] [Related]

  • 48. [Active tyrosinase sites in melanin synthesizing cells; biochemical analysis of coated vesicles (author's transl)].
    Imokawa G, Mishima Y.
    Nihon Hifuka Gakkai Zasshi; 1978 Nov 15; 88(13):913-30. PubMed ID: 104070
    [No Abstract] [Full Text] [Related]

  • 49. Melanosomal antigenic expression on the cell surface and intracellular subunits within melanogenic compartments of pigment cells: analysis by antimelanosome-associated monoclonal antibody.
    Hayashibe K, Mishima Y, Ichihashi M, Kawai M.
    J Invest Dermatol; 1986 Jul 15; 87(1):89-94. PubMed ID: 3522755
    [Abstract] [Full Text] [Related]

  • 50. Endocrine responsiveness in human melanocytes and melanoma cells in culture.
    Fuller BB, Meyskens FL.
    J Natl Cancer Inst; 1981 May 15; 66(5):799-802. PubMed ID: 6262556
    [Abstract] [Full Text] [Related]

  • 51. Tyrosinase protein is expressed also in some neural crest derived cells which are not melanocytes.
    Haninec P, Vachtenheim J.
    Pigment Cell Res; 1988 May 15; 1(5):340-3. PubMed ID: 3148919
    [Abstract] [Full Text] [Related]

  • 52. Monoclonal anti-tyrosine hydroxylase antibodies.
    Hakim AA.
    Proc Soc Exp Biol Med; 1981 Oct 15; 168(1):82-96. PubMed ID: 6119694
    [Abstract] [Full Text] [Related]

  • 53. Genetic control of melanization: isolation and analysis of amelanotic variants from cultured melanotic melanoma cells.
    Pawelek J, Sansone M, Morowitz J, Moellmann G, Godawska E.
    Proc Natl Acad Sci U S A; 1974 Apr 15; 71(4):1073-7. PubMed ID: 4364526
    [Abstract] [Full Text] [Related]

  • 54. A sensitive tyrosinase method for human skin.
    Wittbjer A, Odh G, Rosengren E, Rorsman H.
    Acta Derm Venereol; 1991 Apr 15; 71(5):399-402. PubMed ID: 1684467
    [Abstract] [Full Text] [Related]

  • 55. [Tyrosinase and dopa oxidase in amelanotic melanoma in man].
    Chicewicz M, Roczniak E.
    Wiad Lek; 1977 Aug 01; 30(15):1187-91. PubMed ID: 410164
    [No Abstract] [Full Text] [Related]

  • 56. The possible processing of tyrosinase in the Golgi complexes of the melanocyte.
    Tomita Y, Hariu A, Kato C, Seiji M.
    J Dermatol; 1985 Feb 01; 12(1):43-6. PubMed ID: 3926845
    [No Abstract] [Full Text] [Related]

  • 57. Dopachrome oxidoreductase: a new enzyme in the pigment pathway.
    Barber JI, Townsend D, Olds DP, King RA.
    J Invest Dermatol; 1984 Aug 01; 83(2):145-9. PubMed ID: 6432918
    [Abstract] [Full Text] [Related]

  • 58. The cytotoxicity and apoptosis induced by 4-tertiary butylphenol in human melanocytes are independent of tyrosinase activity.
    Yang F, Sarangarajan R, Le Poole IC, Medrano EE, Boissy RE.
    J Invest Dermatol; 2000 Jan 01; 114(1):157-64. PubMed ID: 10620132
    [Abstract] [Full Text] [Related]

  • 59. Aggregation equilibria of tyrosinase of Harding-Passey mouse melanoma.
    Garcia-Borron JC, Solano F, Iborra JL, Lozano JA.
    Biochem J; 1985 May 15; 228(1):95-101. PubMed ID: 3924035
    [Abstract] [Full Text] [Related]

  • 60. Isolation and characterization of variant cDNAs encoding mouse tyrosinase.
    Terao M, Tabe L, Garattini E, Sartori D, Studer M, Mintz B.
    Biochem Biophys Res Commun; 1989 Mar 15; 159(2):848-53. PubMed ID: 2494997
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 224.